Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.


Insurance regulatory IRDAI gives in-principle approval for Bharti AXA-ICICI Lombard merger deal

Nov 28, 2020, 09:45 IST
Insurance Regulatory and Development Authority of India (Irdai) on Friday gave in-principle approval for the merger of Bharti AXA General with ICICI Lombard.

ICICI Lombard is progressing applications for receipt of requisite approvals from other concerned regulators for the transaction, the insurance company said in a regulatory filing.

Upon closing of the proposed transaction, the consolidated entity will have a market share of about 8.7 per cent on a pro forma basis in the non-life business, it added.

The proposed transaction is expected to result in value creation for all stakeholders through meaningful revenue and operational synergies, it said.

"Further, policyholders should benefit from an enhanced product suite and deeper customer connect touchpoints," the company said, adding the employees of the combined business will also benefit via greater opportunities across functions and geographies.

Marking a major consolidation move in the insurance space, the proposed deal was announced in August this year.

Bharti Enterprises currently owns 51 per cent stake in Bharti AXA General Insurance, while French insurer AXA has 49 per cent.

Post demerger, Bharti AXA General Insurance will cease to be a going concern and both Bharti and AXA will be public shareholders.

Earlier this month, the Competition Commission of India (CCI) had approved the acquisition of Bharti AXA General Insurance by ICICI Lombard. BSE Limited and the National Stock Exchange of India Limited too have issued the Observation Letters in this regard.

SEE ALSO: From Tata Nexon EV and MG ZS EV to Hyundai Kona Electric — here’s how much top electric cars cost in India

AstraZeneca will likely retest its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results
Next Article